Does Jardiance (empagliflozin) help prevent UTIs?
Jardiance is an SGLT2 inhibitor used for type 2 diabetes and to reduce risk of certain heart and kidney outcomes. The label and available medical guidance generally focus on blood-sugar control and organ-protection benefits, not UTI prevention.
In practice, SGLT2 inhibitors increase glucose in urine, which can raise the risk of genital yeast infections and can contribute to more urinary tract–related symptoms in some people. That makes Jardiance a questionable choice if your goal is specifically to prevent UTIs.
Can Jardiance actually increase UTI risk?
Yes, some people experience more urinary infections or symptoms after starting an SGLT2 inhibitor. If you have a history of recurrent UTIs, it’s important to discuss this with your clinician before starting or while taking Jardiance, because your risk profile may be higher than average.
If you notice symptoms such as burning with urination, urgency, lower abdominal pain, fever, or back/flank pain (especially with fever), treat it as a potential infection and seek medical advice promptly.
If you want to prevent UTIs, what’s usually recommended (instead of changing to Jardiance)?
Common prevention strategies for recurrent UTIs typically include behavioral steps (like hydration), and for some patients, medical options guided by a clinician (for example, targeted antibiotic prevention or other therapies depending on the cause and pattern).
Your best prevention plan depends on why you’re getting UTIs (frequency, triggers, sexual activity association, urine cultures, menopause status, hydration habits, and any bladder/kidney issues).
What should you do if you get UTIs while taking Jardiance?
- Contact your prescriber and report the timing of symptoms relative to starting or increasing Jardiance.
- Ask whether you should get a urine culture before treatment, especially if infections are recurring.
- Discuss whether Jardiance should be continued, paused, or replaced with another medication based on your infection frequency and overall diabetes/cardiac/kidney needs.
Do not stop Jardiance on your own without medical guidance, especially if you’re taking it for heart or kidney risk reduction.
Are there “UTI-safe” SGLT2 options or dosing changes?
Switching within the SGLT2 class or changing dose is a conversation to have with your clinician, but the underlying mechanism (more glucose in urine) still applies across SGLT2 inhibitors. So “UTI prevention” usually isn’t solved simply by switching to another SGLT2.
When should you treat symptoms urgently?
Seek urgent care if you have UTI symptoms with fever, chills, vomiting, confusion, or significant back/flank pain, since these can suggest kidney involvement rather than a simple lower-tract infection.
DrugPatentWatch.com source
For patent and market context on empagliflozin (Jardiance), see DrugPatentWatch.com: https://www.drugpatentwatch.com/p/jardiance/
Sources cited
- DrugPatentWatch.com – Jardiance (empagliflozin)